Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarechale Cap. Regulatory News (MAC)

Share Price Information for Marechale Cap. (MAC)

Share Price is delayed by 15 minutes
Get Live Data
7.60    1.05 (16.03%)
Bid:
7.20
Ask:
8.00
Spread: 0.80 (11.111%)
Market Cap: £9.08m
MAC Live PriceLast checked at - London Stock Exchange

Intraday Marechale Cap. Share Chart

Half Yearly Report

21 Dec 2011 07:00

RNS Number : 3716U
Marechale Capital PLC
21 December 2011
 



21 December 2011

 

Marechale Capital plc

("Marechale" or the "Company")

 

Interim Results

 

Marechale Capital plc today announces its unaudited interim results for the six months ended 30 September 2011.

 

Chairman's Statement

 

Marechale has had an encouraging start to the current year, particularly in the context of the current economic environment, and I am able to report that, whilst recording a loss during the half year to September, the Company has successfully completed a number of transactions and generated revenues which are in line with our budget to date. Indeed, in the last week the Company has arranged the funding for the £38m acquisition of seven hotels by a Halcyon Hotels & Resorts plc joint venture (http://www.marechalecapital.com/our-deals/deals/38m-acquisition-for-halcyon-hotels), which has to date returned the business to profitability. We have a healthy pipeline of projects and believe that we are on track to achieve our target for the year to March 2012.

 

Marechale operates as a corporate finance advisory and capital fund raising business focusing on fundraising for growth companies and funds in three sectors in which the team have a long term track record: Leisure and Retail, Renewable Energy and Online Exchanges.

 

Marechale helps management teams to finance or refinance in two key areas of activity; Growth Capital private equity transactions for more established businesses, and Development Capital, fundraising for smaller growth companies, the latter typically being Enterprise Investment Scheme (EIS) qualifying. As part of Marechale's success fee, the Company secures warrants or equity on most of its projects, so shareholders can share in the potential significant upside of the equity value in these businesses.

 

Whilst market conditions are still challenging, and we remain cautious about the immediate outlook, there is a good pipeline of businesses seeking funding, a number of engaged corporate finance projects, and an appetite amongst our investor contacts to invest in high quality investment opportunities. This provides us with a degree of confidence for the second half of the trading year.

 

We hope to give you further positive updates on Marechale after the March 2012 year end.

 

Mark Warde-Norbury

Chairman

20 December 2011

 

 

 

For further information please contact:

 

Marechale Capital

Mark Warde-Norbury / Patrick Booth-Clibborn

 

Tel: +44 (0)20 7628 5582

Smith & Williamson Corporate Finance

Azhic Basirov / David Jones

 

Tel: +44 (0)20 7131 4000

 

 

 

 

 

 

 

Marechale Capital plc

 

 

Income Statement (unaudited)

 

Six months ended 30 September 2011

 

30 Sept

30 Sept

 

2011

2010

 

 

Revenue

237,319

299,658

 

Cost of sales

(25,940)

(25,343)

 

 

Gross profit

211,379

274,315

 

 

Administrative expenses

(297,235)

(264,935)

 

 

Operating (loss)/profit

(85,856)

9,380

 

 

Investment revenues

39

646

 

Other gains and losses

-

-

 

 

Loss/ profit before tax

(85,817)

10,026

 

 

Corporation tax charge

-

-

 

 

(Loss)/ profit for the period

(85,817)

10,026

 

 

 

Earnings per share (Basic and diluted)

52,437,410 shares (2010: 47,437,410)

 

(0.16p)

 

0.02p

 

 

 

 

Balance Sheet (unaudited)

 

As at 30 September 2011

 

30 Sept

30 Sept

 

2011

2010

 

Non-current assets

 

Property, plant and equipment

-

-

 

 

Current assets

 

Available for sale investments

76,351

67,707

 

Trading investments

28,125

-

 

Trade and other receivables

41,608

144,848

 

Cash and cash equivalents

284,870

294,156

 

 

430,954

506,711

 

Total assets

430,954

506,711

 

 

Current liabilities

 

Trade and other payables

(47,771)

(94,682)

 

Corporation tax

-

-

 

 

Total current liabilities

(47,771)

(94,682)

 

 

Net assets

383,183

412,029

 

 

 

Equity

 

Share capital

2,421,871

2,371,872

 

Share premium account

1,227,452

1,177,452

 

Revaluation reserves

21,602

28,324

 

Other reserves

(50,254)

(50,254)

 

Retained earnings

(3,237,488)

(3,115,365)

 

 

Total equity

383,183

412,029

 

 

 

 

Cash Flow Statement (unaudited)

 

Six months ended 30 September 2011

 

30 Sept

30 Sept

 

2011

2010

 

Net cash from operating activities

 

Operating (loss)/ profit

(85,855)

9,380

 

 

Operating cash flows before movements in working capital

(85,855)

9,380

Movement in working capital

 

Decrease/ (increase) in receivables

40,874

(81,874)

 

(Decrease)/ increase in payables

(751)

(23,428)

 

 

40,123

(105,302)

 

Operating cash flow

(45,732)

(95,922)

 

 

Investment activities

 

Interest receivable

38

646

 

Proceeds on disposal of trading investments

-

-

 

Proceeds on disposal of available for sale investments

-

-

 

Expenditure on tangible fixed assets

-

-

 

Expenditure on trading investments

(11,500)

(10,000)

 

 

Cash flow from investing activities

(11,462)

(9,354)

 

 

Financing

 

Issue of share capital

100,000

-

 

Interest payable

-

-

 

 

Cash flow from financing activities

-

-

 

 

Net increase/(decrease) in cash and cash equivalents

42,806

(105,276)

 

 

Cash and cash equivalents at start of period

242,064

399,432

 

Cash and cash equivalents at end of period

284,870

294,156

 

 

Increase/(decrease) in cash and cash equivalents

42,806

(105,276)

 

 

This financial information has been prepared in accordance with IFRS and International Financial Reporting Interpretations Committee ('IFRIC') interpretations adopted by the European Union, and with those parts of the Companies Act 2006 applicable to companies reporting under IFRS, with the prior periods being reported on the same basis.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR DBLFLFLFBFBE
Date   Source Headline
9th Nov 20112:50 pmRNSHolding(s) in Company
22nd Sep 201111:20 amRNSResult of AGM
20th Sep 201110:03 amRNSDirector/PDMR Shareholding
25th Aug 20119:46 amRNSFinal Results
18th Apr 20111:44 pmRNSDirector/PDMR Shareholding
14th Apr 20112:16 pmRNSHolding(s) in Company
12th Apr 20117:00 amRNSDirectorate Change
31st Mar 20113:28 pmRNSIssue of Equity
29th Mar 20113:17 pmRNSDirectorate Appointment & Dealing
28th Mar 20113:39 pmRNSDirector/PDMR Shareholding
16th Mar 20119:20 amRNSDirector/PDMR Shareholding
25th Feb 20113:46 pmRNSHolding(s) in Company
9th Feb 20112:02 pmRNSDirector/PDMR Shareholding
19th Jan 20111:34 pmRNSDirector/PDMR Shareholding
13th Jan 20114:19 pmRNSHolding(s) in Company
11th Jan 201112:27 pmRNSDirector/PDMR Shareholding
15th Dec 201012:00 pmRNSHalf Yearly Report
29th Sep 20103:06 pmRNSResult of AGM
22nd Sep 201010:34 amRNSDirector/PDMR Shareholding
7th Sep 201012:00 pmRNSFinal Results and Notice of General Meeting
17th Mar 20109:00 amRNSChange of Adviser
22nd Feb 20103:15 pmRNSResult of GM
12th Feb 201012:00 pmRNSDirector/PDMR Shareholding
4th Feb 201011:00 amRNSDirector/PDMR Shareholding
29th Jan 201012:00 pmRNSNotice of General Meeting
12th Jan 20107:00 amRNSApplication for New Ordinary Shares
23rd Dec 20092:31 pmRNSHalf Yearly Report
17th Dec 20095:15 pmRNSResult of AGM
7th Dec 200912:28 pmRNSHoldings in Company / Directors Dealings
23rd Nov 20097:00 amRNSAcquisition and AGM
23rd Oct 20099:17 amRNSHolding in Company
15th Oct 20092:41 pmRNSChange of Name of Nominated Adviser and Broker
30th Sep 20094:00 pmRNSAnnual Report & Accounts
18th Sep 20097:00 amRNSNotifiable Interests
18th Sep 20097:00 amRNSHolding in Company
28th Aug 20092:30 pmRNSAcquisition of Whim Gully Capital LLP
28th Aug 20092:30 pmRNSPreliminary Results and Notice of General Meeting
21st Jul 20097:00 amRNSDisposal
6th Aug 200810:59 amRNSDirector/PDMR Shareholding
23rd Jun 20087:00 amRNSAppointment of joint broker

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.